The participants will be able to review and discuss research regarding non-hepatic malignancy in the candidate, the donor or the recipient, including selection criteria/indications, prognostic models, surveillance strategies, novel therapies and management.
The participants will gain insight into innovations that lead to improvement in the field of liver transplantation in candidates or donors with a history of malignancy, and in recipients with de novo cancer, both in adult and pediatric populations.
When
Monday, January 18, 2021 · 3:00 p.m.
Berlin (GMT +1:00)
WEBINAR ENDED
Agenda
Introduction - José Antonio Pons, MD, PhD
Liver transplantation outcomes and current candidates profile - Nazia Selzner, MD, PhD
Outlining the current approach to non-hepatic cancer in LT - John Roberts, MD
Role of immunosuppression in cancer - Manuel Rodriguez-Perálvarez, MD, PhD
New anti-cancer therapies: Beyond the conventional multidisciplinary cancer care - Milind Javle, MD